跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,069 条关于
“NaV channel”
全部
10,069
临床试验
8,424
药物
837
机构
64
资讯
744
7个月前
Grünenthal Initiates Phase I Trial of Novel NaV 1.8 Inhibitor for Non-Opioid Pain Management
去年
Praxis Precision Medicines Presents Promising Epilepsy Pipeline Updates at AES 2024
9个月前
Praxis Precision Medicines Reports Positive EMBOLD Study Results for Relutrigine in Rare Epileptic Encephalopathies
去年
Praxis Precision Medicines Advances Pipeline with Relutrigine into Late-Stage Development
去年
FDA Grants Rare Pediatric Disease Designation to Praxis' Relutrigine for Dravet Syndrome
去年
Dogwood Therapeutics' Novel Pain Drug Halneuron® Drives 368% Stock Rally Amid Phase 2b Trial Launch
去年
Metrion Biosciences Unveils Breakthrough NaV1.9 Screening Assay to Accelerate Non-Opioid Pain Therapeutics Development
去年
Ligand's Pelthos Therapeutics to Merge with Channel Therapeutics in $50M Deal Focused on Molluscum Treatment
去年
Channel Therapeutics and Pelthos Therapeutics Merge to Accelerate Zelsuvmi Launch for Molluscum Contagiosum
去年
Dogwood Therapeutics Converts $19.5M Debt to Equity, Advances Phase 2b Trial of Non-Opioid Pain Treatment
第 1 页,共 75 页
上一页
下一页